Symbol: |
LYAR
|
Description: |
Ly1 antibody reactive homolog (mouse) [Source:HGNC Symbol;Acc:26021]
|
Location: |
Chr4:4269428-4291896[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:332
Gene |
Compound |
Gen_sig |
Exp_pattern |
LYAR |
NSC 677159 |
0.045 |
Down |
LYAR |
NSC 677187 |
0.016 |
Down |
LYAR |
NSC 677194 |
0.009 |
Down |
LYAR |
Uracil, 3-methyl-6-(phenylhydrazino)- |
0.01 |
Down |
LYAR |
10H-Phenothiazine, 10-(4-chlorobutyl)-1,3,4-trifluoro- 2-nitro- |
0.001 |
Down |
LYAR |
NSC 677747 |
0.001 |
Down |
LYAR |
16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol |
0.036 |
Down |
LYAR |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.011 |
Down |
LYAR |
NSC 678058 |
0.004 |
Up |
LYAR |
4H-1,3,6,2-Dioxazaphosphocinium, 4-hexadecyltetrahydro- 2,6,6-trimethyl-, bromide, 2-oxide |
0.048 |
Down |
LYAR |
1H-Indole, 3,3'-(2,5-piperazinediyl)bis(6-bromo-, (+-)-, dihydrobromide |
0.024 |
Down |
LYAR |
Pyrimidin-2-amine, 4-(2-hydroxy-4-methoxyphenyl)-6-phenyl- N-(phenylmethylene)- |
0.006 |
Down |
LYAR |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- |
0.018 |
Down |
LYAR |
Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- |
0.017 |
Down |
LYAR |
Adenine, 9-[1,2-bis(ethoxycarbonyl)ethenyl]-, trans- |
0.017 |
Down |
Expression pattern: Sensitivity / Resistance
Total:23 Current:12
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:null
SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|